As of 2026-04-02, 司美格鲁肽系列产品（Ozempic和Wegovy）'s data on the DeepSeek platform in the 医药制造 category shows: The overall mention rate is 0.00%, above the industry average by 0.0 percentage points, showing notable performance. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
司美格鲁肽系列产品（Ozempic和Wegovy）'s Mention Rate is 0.00%, lower than 0.6% of competitors
司美格鲁肽系列产品（Ozempic和Wegovy）'s First Mention is 0.00%, lower than 0.9% of competitors
司美格鲁肽系列产品（Ozempic和Wegovy）'s Preferred Rate is 0.00%, lower than 100.0% of competitors
司美格鲁肽系列产品（Ozempic和Wegovy）'s Positive Rate is 0.00%, lower than 8.9% of competitors
司美格鲁肽系列产品（Ozempic和Wegovy）'s Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 司司美格鲁肽系列产品（Ozempic和Wegovy） (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
